Telomir Pharmaceuticals Inc. logo

Telomir Pharmaceuticals Inc. (TELO)

Market Closed
4 Dec, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 36
+0.04
+3.03%
$
44.35M Market Cap
- P/E Ratio
- Div Yield
197,539 Volume
- Eps
$ 1.32
Previous Close
Day Range
1.3 1.38
Year Range
1.12 7.08
Want to track TELO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
3 Feb 2026 (In 2 months)
-
Cons. EPS
-
EPS
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
2 Feb 2026 (In 1 month)
-
Cons. EPS
-
EPS
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
11 Nov 2025
-
Cons. EPS
-
EPS
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
10 Nov 2025
-
Cons. EPS
-
EPS
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
11 Aug 2025
-
Cons. EPS
-
EPS
Telomir Pharmaceuticals Inc. logo
TELO Telomir Pharmaceuticals Inc.
26 Feb 2025
-
Cons. EPS
-
EPS

TELO Earnings Reports FAQ

What is the earnings per share (EPS) for TELO?

EPS data for TELO is currently not available, as Telomir Pharmaceuticals Inc has not reported recent earnings.

What is the company's earnings growth rate?

Telomir Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-02-02, based on the TELO's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Telomir Pharmaceuticals Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for TELO at this time, as Telomir Pharmaceuticals Inc has no recent EPS data to calculate it.